These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25148516)
41. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis. Li J; Li S; Bai C; Liu H; Gramatica P J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994 [TBL] [Abstract][Full Text] [Related]
42. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. Gujjar R; Marwaha A; El Mazouni F; White J; White KL; Creason S; Shackleford DM; Baldwin J; Charman WN; Buckner FS; Charman S; Rathod PK; Phillips MA J Med Chem; 2009 Apr; 52(7):1864-72. PubMed ID: 19296651 [TBL] [Abstract][Full Text] [Related]
44. 2,4-Diaminothienopyrimidines as orally active antimalarial agents. González Cabrera D; Le Manach C; Douelle F; Younis Y; Feng TS; Paquet T; Nchinda AT; Street LJ; Taylor D; de Kock C; Wiesner L; Duffy S; White KL; Zabiulla KM; Sambandan Y; Bashyam S; Waterson D; Witty MJ; Charman SA; Avery VM; Wittlin S; Chibale K J Med Chem; 2014 Feb; 57(3):1014-22. PubMed ID: 24446664 [TBL] [Abstract][Full Text] [Related]
45. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1 Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164 [TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo evaluation of the antimalarial MMV665831 and structural analogs. Ding S; Fike KR; Klemba M; Carlier PR Bioorg Med Chem Lett; 2020 Sep; 30(17):127348. PubMed ID: 32738996 [TBL] [Abstract][Full Text] [Related]
47. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice. Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815 [TBL] [Abstract][Full Text] [Related]
48. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo. Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033 [TBL] [Abstract][Full Text] [Related]
49. Antimalarial Benzimidazole Derivatives Incorporating Phenolic Mannich Base Side Chains Inhibit Microtubule and Hemozoin Formation: Structure-Activity Relationship and Dziwornu GA; Coertzen D; Leshabane M; Korkor CM; Cloete CK; Njoroge M; Gibhard L; Lawrence N; Reader J; van der Watt M; Wittlin S; Birkholtz LM; Chibale K J Med Chem; 2021 Apr; 64(8):5198-5215. PubMed ID: 33844521 [TBL] [Abstract][Full Text] [Related]
50. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Fleck SL; Robinson BL; Peters W; Thévin F; Boulard Y; Glénat C; Caillard V; Landau I Ann Trop Med Parasitol; 1997 Jan; 91(1):25-32. PubMed ID: 9093426 [TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin. Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279 [TBL] [Abstract][Full Text] [Related]
52. Synthesis and antimalarial activity of E-2-quinolinylbenzocycloalcanones. Charris JE; Domínguez JN; Gamboa N; Rodrigues JR; Angel JE Eur J Med Chem; 2005 Sep; 40(9):875-81. PubMed ID: 15878218 [TBL] [Abstract][Full Text] [Related]
53. Antrocaryon micraster (A. Chev. And Guillaumin) stem bark extract demonstrated anti-malaria action and normalized hematological indices in Plasmodium berghei infested mice in the Rane's test. Kumatia EK; Ayertey F; Appiah-Opong R; Bolah P; Ehun E; Dabo J J Ethnopharmacol; 2021 Feb; 266():113427. PubMed ID: 33022339 [TBL] [Abstract][Full Text] [Related]
54. HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages. Hobbs CV; Voza T; De La Vega P; Vanvliet J; Conteh S; Penzak SR; Fay MP; Anders N; Ilmet T; Li Y; Borkowsky W; Krzych U; Duffy PE; Sinnis P J Infect Dis; 2012 Dec; 206(11):1706-14. PubMed ID: 23125449 [TBL] [Abstract][Full Text] [Related]
55. Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of Malaria. Mayoka G; Njoroge M; Okombo J; Gibhard L; Sanches-Vaz M; Fontinha D; Birkholtz LM; Reader J; van der Watt M; Coetzer TL; Lauterbach S; Churchyard A; Bezuidenhout B; Egan TJ; Yeates C; Wittlin S; Prudêncio M; Chibale K J Med Chem; 2019 Jan; 62(2):1022-1035. PubMed ID: 30562027 [TBL] [Abstract][Full Text] [Related]